NCT06756854View on ClinicalTrials.gov

Low-Level Laser Therapy and Injectable Platelet-Rich Fibrin for Thin Gingival Phenotype.

PHASE3CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

May 14, 2024

Study Completion Date

June 15, 2024

Conditions
Periodontal Diseases
Interventions
BIOLOGICAL

Biologic Agent: injectable platelet rich fibrin.

injection of I-PRF to thin gingival phenotype 3 times with 7 days interval between sessions.

OTHER

injecable platelet rich fibrin, and low level laser therapy radiation.

injection of I-PRF+ exposure to LLLT to thin gingival phenotype 3 times with 7 days interval between sessions.

Trial Locations (1)

Unknown

Alaa Elsayed, Cairo

All Listed Sponsors
lead

Faculty of Dental Medicine for Girls

OTHER_GOV

NCT06756854 - Low-Level Laser Therapy and Injectable Platelet-Rich Fibrin for Thin Gingival Phenotype. | Biotech Hunter | Biotech Hunter